Rank;Global Rank;Institution;Country;Sector
1;13;Daimler AG;DEU;Companies
2;37;SAP AG;DEU;Companies
3;241;France Telecom, S.A.;FRA;Companies
4;257;SINTEF Group;NOR;Companies
5;367;Robert Bosch GmbH;DEU;Companies
6;378;Siemens AG;DEU;Companies
7;581;STMicroelectronics;FRA;Companies
8;708;VTT Technical Research Centre of Finland;FIN;Companies
9;791;BASF AG;DEU;Companies
9;791;Bayer AG Germany;DEU;Companies
9;791;GlaxoSmithKline, United Kingdom;GBR;Companies
9;791;Microsoft Research Cambridge;GBR;Companies
13;1066;Infineon Technologies;DEU;Companies
13;1066;STMicroelectronics;ITA;Companies
15;1361;Electricite de France, S.A.;FRA;Companies
15;1361;Thales Group France, S.A.;FRA;Companies
17;1892;Bruker Corporation;DEU;Companies
17;1892;Merck KGaA, Germany;DEU;Companies
17;1892;Novartis Farma, S.p.A., Italy;ITA;Companies
17;1892;Renault, S.A.S.;FRA;Companies
17;1892;Rolls-Royce plc;GBR;Companies
22;2905;AIRBUS Germany;DEU;Companies
22;2905;AstraZeneca, Sweden;SWE;Companies
22;2905;AstraZeneca, United Kingdom;GBR;Companies
22;2905;Atomic Weapons Establishment;GBR;Companies
22;2905;Eli Lilly and Company Ltd., United Kingdom;GBR;Companies
22;2905;GlaxoSmithKline, Belgium;BEL;Companies
22;2905;Hoffmann-La Roche, GmbH., Germany;DEU;Companies
22;2905;Hoffmann-La Roche, Ltd., Switzerland;CHE;Companies
22;2905;IMEC International;BEL;Companies
22;2905;Novartis Institutes for Biomedical Research, Switzerland;CHE;Companies
22;2905;Novartis, Switzerland;CHE;Companies
22;2905;Novo Nordisk A/S;DNK;Companies
22;2905;Pfizer Inc., United Kingdom;GBR;Companies
22;2905;Philips Research Eindhoven;NLD;Companies
22;2905;Sincrotrone Trieste;ITA;Companies